Assessment of serum lipids in Nigerians with type 2 diabetes mellitus complications

Pakistan Journal of Medical Sciences

Volumn 23, Issue 5, 2007, Pages 708-712

  Idogun, E S ^a   Unuigbe, E I ^a   Ogunro, P S ^b   Akinola, O T ^c   Famodu, A A ^c  

^a UNIVERSITY OF BENIN   (Nigeria)

^b Ladoke Akintola University   (Nigeria)

^c NONE

Author keywords

Dyslipidaemia; Nigerians; Type 2 DM complications

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 36949004131     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Taskinem MR. Quantitative and qualitative lipoprotein abnormalities in Diabetes mellitus. Diabetes 1992;41:12-17.
2. Jarikre AE, Oke DA, Idogun ES. Interpreting plasma lipid profile patterns in Nigerian Africans using total cholesterol ester to HDL cholesterol ratio: Nig J Int Med 1999;2(4):92-4.
3. Abdul RAN, Olufunsho F. Hyperlipidaemia among Saudi diabetic patients - pattern and clinical characteristics. Ann Saudi Med 1995;15(3):240-3.
4. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
5. National High Blood Pressure Education Program: Working Group report on primary prevention of hypertension. Arch Intern Med 1993;153:186-208.
6. Abell LL, Levy BB, Brodie BB, Kendall FE. Simplified methods for the estimation of the total cholesterol in serum and demonstration of specificity. J Biol Chem 1952;195:357-66.
7. Lopez-Virella ML. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-90.
8. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476-82.
9. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin Chem 1972;18:499-502.
10. Fabian W, Majkowska L, Stefanski A, Moleda P. Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by the general practitioners. Przegl Lek 2005;62(4):201-5.
11. Vinter - Repalust N, Jurkomo L, Katie M, Simunovic R, Petric D. Disease duration, patient compliance and presence of complications in diabetic patients. Acta Med Croatica 2007;61(1):57-62.
12. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestic heart failure. J Am Coll Cardiol 2004;43(5):771-7.
13. Joslin EP. Arteriosclerosis and diabetes. Ann Chim Med 1927;5:1061-79.
14. Reaven GM. Non insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism and atherosclerosis. Metabolism 1987;36:1-8.
15. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
16. Akbar DH. Hyperlipidaemia in diabetic patients in Saudi Arabia. Diabetes International 2001;11(1):17-18.
17. Prasad K, George L.B. Renal Mortality Associated with NIDDM. J Diab Comp 1997;11:60-8.
18. Paolo F, Peter W. Insulin, Insulin sensitivity and hypertension. J hypertension 1990;8:491-500.
19. Andrew JK, Clifford JB. Type 2 diabetes. London, Royal Society of Medicine Press; 1994;107.
20. Emile E, WJR, Jorge JG, Jane ER. Lipid level differences and hypertension effect in Black and Whites with type 2 Diabetes. Ethnicity Dis 1993;3:242-9.
21. The lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American Populations: the Lipid Research Clinic Program Prevalence study. Circulation 1970;60:42739.
22. Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor. Prog Cardiovas Dis 1984;26:373-412.